1. Home
  2. CBNK vs RZLT Comparison

CBNK vs RZLT Comparison

Compare CBNK & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBNK

Capital Bancorp Inc.

SELL

Current Price

$38.71

Market Cap

560.3M

Sector

Finance

ML Signal

SELL

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.64

Market Cap

471.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBNK
RZLT
Founded
1974
2010
Country
United States
United States
Employees
N/A
58
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
471.0M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
CBNK
RZLT
Price
$38.71
$4.64
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
★ $43.56
$9.80
AVG Volume (30 Days)
133.0K
★ 1.7M
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 1.44%
N/A
EPS Growth
★ 60.85
23.47
EPS
★ 1.60
N/A
Revenue
N/A
N/A
Revenue This Year
$9.44
N/A
Revenue Next Year
$10.21
$2,481.32
P/E Ratio
$24.32
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.40
$1.07
52 Week High
$40.70
$11.46

Technical Indicators

Market Signals
Indicator
CBNK
RZLT
Relative Strength Index (RSI) 57.58 58.48
Support Level $35.70 $4.36
Resistance Level $40.70 $4.71
Average True Range (ATR) 0.75 0.32
MACD 0.08 0.10
Stochastic Oscillator 61.20 77.39

Price Performance

Historical Comparison
CBNK
RZLT

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Share on Social Networks: